Fountain Life Targets Superpower Market
Superpower
This is the clearest sign that longevity care is moving from concierge medicine into consumer subscription territory. Fountain Life built its brand around $10,500 and up memberships, full body MRI, biomarker testing, restorative therapies, and always on care. A plan below $1,000 would pull the company down into the same buyer decision as Superpower, where the question is less who wants a luxury clinic and more who can package testing, interpretation, and follow through at mass affluent pricing.
-
Superpower sits in the low price, high frequency lane. Its core plans are $199 and $499 annually, built around 100 plus biomarker blood panels, app based interpretation, clinician consults, add on testing, and supplement or prescription upsells. That makes it much closer to a software enabled diagnostics subscription than a traditional longevity center.
-
Fountain Life starts from the opposite model. Its memberships begin at $10,500, center on annual or unlimited MRI and other in person diagnostics, and layer in physicians, coaches, and care coordination. A cheaper entry plan would likely strip out most of the labor and imaging intensity, then keep the brand and data layer, which is exactly where Superpower already operates.
-
The broader market is already compressing toward this range. Function Health built a large blood testing business at $499 per year, then cut its annual membership to $365 while adding imaging and AI features. That shows the category is training consumers to expect broad preventive testing for a few hundred dollars, not five figures.
The next phase is a stack war, not a clinic war. Premium operators are moving downmarket with lighter plans, while testing first platforms are moving up with imaging, AI copilots, and employer distribution. The winners are likely to be the companies that turn a one time lab result into an ongoing habit, then expand from diagnostics into treatment, supplements, and covered care.